Costs and efficacy of tinzaparin sodium versus acenocoumarol for the secondary prevention of venous thromboembolism

Trial Profile

Costs and efficacy of tinzaparin sodium versus acenocoumarol for the secondary prevention of venous thromboembolism

Not stated
Phase of Trial: Phase IV

Latest Information Update: 13 Feb 2011

At a glance

  • Drugs Acenocoumarol; Tinzaparin sodium
  • Indications Pulmonary embolism
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top